Intrinsic Value of S&P & Nasdaq Contact Us

Healthcare Realty Trust Incorporated HR NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
36/100
1/7 Pass
SharesGrow Intrinsic Value
$14.40
-19.3%
Analyst Price Target
$19.67
+10.3%

Healthcare Realty Trust Incorporated (HR) — Analyst outlook / Analyst consensus target is. Based on 29 analyst ratings, the consensus is bullish — 7 Buy, 20 Hold, 2 Sell.

The consensus price target is $19.67 (low: $19.00, high: $21.00), representing an upside of 10.3% from the current price $17.84.

Analysts estimate Earnings Per Share (EPS) of $-1.55 and revenue of $1.25B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.81 vs est $-1.55 (missed -16.4%). 2025: actual $-0.71 vs est $-0.75 (beat +5.6%). Analyst accuracy: 90%.

HR Stock — 12-Month Price Forecast

$19.67
▲ +10.26% Upside
Average Price Target
Based on 29 Wall Street analysts offering 12-month price targets for Healthcare Realty Trust Incorporated, the average price target is $19.67, with a high forecast of $21.00, and a low forecast of $19.00.
The average price target represents a +10.26% change from the last price of $17.84.
Highest Price Target
$21.00
Average Price Target
$19.67
Lowest Price Target
$19.00

HR Analyst Ratings

Hold
29
Ratings
7 Buy
20 Hold
2 Sell
Based on 29 analysts giving stock ratings to Healthcare Realty Trust Incorporated in the past 3 months
Rating breakdown
Buy
7 24%
Hold
20 69%
Sell
2 7%
24%
Buy
7 analysts
69%
Hold
20 analysts
7%
Sell
2 analysts

EPS Estimates — HR

90%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$1.81 vs Est –$1.55 ▼ 14.1% off
2025 Actual –$0.71 vs Est –$0.75 ▲ 5.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — HR

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $1.249B vs Est $1.246B ▲ 0.3% off
2025 Actual $1.181B vs Est $1.161B ▲ 1.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message